$380K Fox Foundation Grant Extends California Parkinson’s Registry for Year
The California Parkinson’s Disease Registry (CPDR) will continue through June 2021, after gaining support from the state’s governor and…
Articles by David Melamed, PhD
NIH Grant Supports Syn-One Test for Detecting Parkinson’s, Other Disorders Early
The U.S. National Institutes of Health (NIH) has given a Small Business Innovation Research (SBIR) grant totaling…
Pharmather to Advance Ketamine as Potential Dyskinesia Treatment
Pharmather has entered into an exclusive licensing agreement with the University of Arizona, allowing the company…
STADA Acquires Triple Combo Pump Therapy, Seeks European Approvals
STADA Arzneimittel has announced the acquisition of Sweden-based Lobsor Pharmaceuticals, gaining the rights to its triple-combination therapy of…
BIAL Acquires Parkinson’s Treatment LTI-291, Opens US Research Center
Portuguese pharmaceutical company BIAL has announced the opening of a Parkinson’s disease research facility in Cambridge, Mass., as part…
$7M Grant Awarded to Develop NISNEM (Non-Invasive, Individual Brain Cell Imaging Technology)
The Engineering and Physical Research Sciences Council (EPRSC) at UK Research and Innovation (UKRI) has awarded researchers at…
iLCT Program Pledges $6.75M for Clinical Trials for Potential Treatments
The International Linked Clinical Trials (iLCT) program, a collaborative effort from The Cure Parkinson’s Trust (CPT), the…
Trial Testing CuraSen’s CST-2032 for Neurodegenerative Disease Begins Dosing
The first participants have been dosed in the initial part of a Phase 1 clinical trial evaluating the investigational compound…
American Parkinson Disease Association Awards First Diversity Research Grant
The American Parkinson Disease Association (APDA) has awarded $1.4 million toward research into Parkinson’s disease for 2020–2021, including…
First Patients Dosed in Clinical Trial Investigating ANVS401 as Treatment for Parkinson’s and Alzheimer’s
The first three patients have been dosed in a Phase 2a clinical trial investigating the safety and effectiveness of…